InvestorsHub Logo
Followers 91
Posts 4306
Boards Moderated 1
Alias Born 01/19/2014

Re: ClayTrader post# 1726

Saturday, 02/09/2019 4:54:55 PM

Saturday, February 09, 2019 4:54:55 PM

Post# of 1900
The company is trading under its cash on hand at $.61. According to the last quarterly filing, the stock had until May 29th to regain $1 compliance.

So, why now? I have a suspicion that either an investment fund has communicated interest in making an investment or big pharma may want to ink a partnership deal or even a buyout.

Bank of America set a $2.15 price target in mid January.

I bought more shares than I care to mention Friday afternoon. The science is promising, and the company has been around for decades. I am betting on a share price in the mid 20s before summer begins. They can always invest in other companies as well. I would love to see them buy out Oncolix to get to Prolanta.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CLDX News